Profiling bodily fluids is crucial for monitoring and discovering metabolic markers of disease. In this study, a comprehensive analysis approach based on 1D-LC-MS/MS and 2D-LC-MS/MS was applied to profile normal human urine metabolites from 348 children and 315 adults. A total of 2357 metabolites were identified, including 1831 endogenous metabolites and 526 exogenous ones. In total, 1005 metabolites were identified in urine for the first time. The urinary metabolites were mainly involved in amino acid metabolism, small molecule biochemistry, lipid metabolism and cellular compromise. The comparison of adult’s and children’s urine metabolomes showed adults urine had more metabolites involved in immune response than children’s, but the function of binding of melatonin, which belongs to the endocrine system, showed a higher expression in children. The urine metabolites detected by the 1D-LC-MS/MS method were mainly related to amino acid metabolism and lipid metabolism, and the 2D-LC-MS/MS method not only explored metabolites from 1D-LC-MS/MS but also metabolites related to cell signaling, cell function and maintenance, etc. Our analysis comprehensively profiled and functionally annotated the metabolome of normal human urine, which would benefit the application of urinary metabolome to clinical research.
Background/Objectives: This study aimed to apply a multicriteria decision analysis to assess the comprehensive value of omalizumab for moderate to severe pediatric asthma in China. Methods: A multidisciplinary panel of 17 experts assessed the value of omalizumab plus the standard of care (SOC) using SOC alone as a comparator. We developed a hierarchical criteria system with six main domains and 15 specific criteria. To establish a comprehensive evidence matrix, we integrated findings from a systematic literature review (SLR) and a real-world pharmacovigilance study based on the FAERS database. The overall estimated value of each strategy was obtained by combining the criterion weights with the score of each strategy in each criterion. A sensitivity analysis was conducted to validate the robustness of the results. Results: According to the AHP methods, the following weights were assigned to the criteria: safety (38.55%), effectiveness (28.85%), economics (9.65%), innovation (8.24%), accessibility (7.84%), and applicability (6.88%). Based on the evidence matrix, omalizumab plus SOC scored higher than the SOC in effectiveness (2.53 vs. 1.94) and innovation (0.70 vs. 0.15). When the weight and score of each strategy in each criterion were combined, the overall estimated values were 7.40 points for omalizumab plus SOC and 7.19 points for SOC. Conclusions: Adding omalizumab was assessed as a conditionally recommended strategy for treating moderate to severe asthma in Chinese children.
Background: Abdominal Henoch - Schönlein purpura (AHSP), being the most prevalent form of Henoch - Schönlein purpura, has a significant impact on the short - term prognosis of the disease and often involves the kidneys, leading to renal complications that affect children's long - term prognosis. However, the existing early assessment criteria for AHSP and its renal complications are inadequate. The urinary proteome may offer valuable insights. Objective: To confirm the significance of urinary proteomics in the early detection of AHSP and its renal complications in children. Methods: The urinary proteome of AHSP patients (with and without renal involvement) was compared with that of healthy controls using liquid chromatography - tandem mass spectrometry (LC - MS/MS) in data - independent acquisition (DIA) mode. Differentially expressed proteins were analyzed through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Mfuzz was employed to analyze the expression levels of proteins related to disease onset and progression. The STRING database was used for protein - protein interaction analysis of relevant biological pathways. Selected differential proteins were verified using parallel reaction monitoring (PRM). Results: A total of 441 dysregulated differentially expressed proteins (DEPs) were associated with the pathogenesis of AHSP, mainly related to cell adhesion, signal transduction or regulation, and reactions or pathways mediated by inflammatory cells or factors, and predominantly enriched in the lysosomal pathway. A total of 275 DEPs related to renal complications of AHSP were mainly associated with immune processes mediated by immunoglobulins, predominantly enriched in the regulatory pathways of the actin cytoskeleton. Time series clustering analysis identified 10 discrete clusters; three upregulated and two downregulated clusters were chosen to form respective panels. These panels involved various biological processes such as immune and inflammatory processes, lipid metabolism, glycosylation, coagulation, oxidative detoxification processes, and the Wnt signaling pathway, with several important biological pathways being enriched. Protein - protein interaction analysis of key pathways revealed three distinct MCODE networks, mainly involving proteins related to immunity, coagulation, collagen, and integrins. In the validation phase, at least eight urinary proteins useful for diagnosing AHSP or its renal complications were identified, demonstrating good diagnostic performance. Conclusion: This study offers novel perspectives on the pathogenesis of AHSP and its renal complications in children, and the related proteins may serve as potential biomarkers for diagnosing AHSP and identifying the onset of renal damage. The findings of this study emphasize the importance of urinary proteomics in understanding the disease mechanisms and provide a basis for further research on early diagnosis and treatment.